Not So Fast

Claims made by Hisashi Moriguchi — a visiting researcher at the University of Tokyo — about using modified stem cells to successfully treat a patient with terminal heart failure could be false, reports Nature News.

According to the article, Moriguchi says he had invented a method of reprogramming induced pluripotent stem cells using two chemicals. He also claimed that the iPS cells could be differentiated using a "supercooling method" that he invented.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Not From These Mice

Oh, Oops

Yoshiki Sasai Dies

Retraction Time

An Australian study of personalized medicine has run into problems as it recruits patients.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.